Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John J Baldwin

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Future Medicinal Chemistry|October 26, 2011
Is drug discovery dead?John J Baldwin
Future Medicinal Chemistry|August 1, 2014
Pharmaceutical R&D: an age of change?John J Baldwin
Future Medicinal Chemistry|June 11, 2015
Drug discovery and development 2014: Returning toward the norm?John J Baldwin
Combinatorial Chemistry & High Throughput Screening|August 24, 2006
Exploring structure-activity relationships of tricyclic farnesyltransferase inhibitors using ECLiPS librariesLaura L Rokosz, Chia-Yu Huang, John C Reader, et al.
Journal of Molecular Graphics & Modelling|August 16, 2014
An electronic environment and contact direction sensitive scoring function for predicting affinities of protein-ligand complexes in Contour(®)Peter R Lindblom, Guosheng Wu, Zhijie Liu, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Surfing the piperazine core of tricyclic farnesyltransferase inhibitorsLaura L Rokosz, Chia-Yu Huang, John C Reader, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2007
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonistsPurakkattle Biju, Arthur Taveras, Younong Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zincChia-Yu Huang, Tara M Stauffer, Corey L Strickland, et al.
Bioorganic & Medicinal Chemistry|December 27, 2005
Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonistsJun Chiba, Gensuke Takayama, Tohru Takashi, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonistJun Chiba, Nobuo Machinaga, Tohru Takashi, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Future Medicinal Chemistry|October 26, 2011
Is drug discovery dead?John J Baldwin
Future Medicinal Chemistry|August 1, 2014
Pharmaceutical R&D: an age of change?John J Baldwin
Future Medicinal Chemistry|June 11, 2015
Drug discovery and development 2014: Returning toward the norm?John J Baldwin
Combinatorial Chemistry & High Throughput Screening|August 24, 2006
Exploring structure-activity relationships of tricyclic farnesyltransferase inhibitors using ECLiPS librariesLaura L Rokosz, Chia-Yu Huang, John C Reader, et al.
Journal of Molecular Graphics & Modelling|August 16, 2014
An electronic environment and contact direction sensitive scoring function for predicting affinities of protein-ligand complexes in Contour(®)Peter R Lindblom, Guosheng Wu, Zhijie Liu, et al.
Bioorganic & Medicinal Chemistry Letters|October 6, 2005
Surfing the piperazine core of tricyclic farnesyltransferase inhibitorsLaura L Rokosz, Chia-Yu Huang, John C Reader, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2007
3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonistsPurakkattle Biju, Arthur Taveras, Younong Yu, et al.
Bioorganic & Medicinal Chemistry Letters|November 18, 2005
Guiding farnesyltransferase inhibitors from an ECLiPS library to the catalytic zincChia-Yu Huang, Tara M Stauffer, Corey L Strickland, et al.
Bioorganic & Medicinal Chemistry|December 27, 2005
Synthesis, biological evaluation, and pharmacokinetic study of prolyl-1-piperazinylacetic acid and prolyl-4-piperidinylacetic acid derivatives as VLA-4 antagonistsJun Chiba, Gensuke Takayama, Tohru Takashi, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Identified a morpholinyl-4-piperidinylacetic acid derivative as a potent oral active VLA-4 antagonistJun Chiba, Nobuo Machinaga, Tohru Takashi, et al.
Pageof 2